About Cytochroma

Business Strategy

Management Team

Scientific Advisory Board

Partners

Career Opportunities

 

Business Strategy:

Cytochroma’s strategy is to leverage its knowledge of chronic kidney disease (CKD) and proven talent to discover, develop and commercialize leading-edge therapies for the CKD market.
The key elements of this strategy are to:

  • Leverage a strategic partnership with Mitsubishi Tanabe Pharma Corporation to develop and commercialize breakthrough products;
  • Apply existing management expertise to develop, market and sell products for CKD
  • Expand an established key opinion leader network in nephrology and vitamin D molecular physiology;
  • Leverage existing expertise in vitamin D intellectual property;
  • Develop and out-license additional product offerings; and
  • In-license and/or acquire new products.